BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Business

  Pivotal Therapeutics Inc. Reports 1st Quarter 2012 Results

  May 29, 2012

   · 

  1 min read
• Drug Development

  Andromeda Announces FDA Orphan Drug Designation for DiaPep277 for the Treatment of Type 1 Diabetes With Residual Beta Cell Function

  May 29, 2012

   · 

  1 min read
• Drug Development

  ChemoCentryx, Inc. Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European Renal Association - European Dialysis and Transplant Association Congress

  May 29, 2012

   · 

  1 min read
• Biotech Bay

  ChemoCentryx, Inc. Announces Transfer of Existing Shares Between Current Stockholders

  May 29, 2012

   · 

  1 min read
• Roche Limits Drug Billing Credit for Spanish, Portuguese Clinics

  May 29, 2012

   · 

  1 min read
• European Medicines Evaluation Agency Clears Roche Cancer Drug MabThera

  May 29, 2012

   · 

  1 min read
• Policy

  High Court Rules for AstraZeneca PLC Over Deaths from Iressa

  May 29, 2012

   · 

  1 min read
• Policy

  Medtronic, Inc. CEO: Supreme Court Ruling Won’t Stop Health Care Integration

  May 29, 2012

   · 

  1 min read
• Business

  TransCorp Spine Inc. Names Christopher Welch President and Chief Executive Officer

  May 29, 2012

   · 

  1 min read
• Pharm Country

  3 Reasons to Buy Johnson & Johnson

  May 29, 2012

   · 

  1 min read